Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

IMRT Followed by CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume

Phase: N/A Priority: Normal
NCT ID: NCT03206385 Org: User:
Start: 05/31/17 End: 12/31/23 Due: 12/31/24

Stereotactic Radiotherapy for Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03286023 Org: User:
Start: 10/31/14 End: 12/31/22 Due: 12/31/23

Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03199144 Org: User:
Start: 04/20/17 End: 03/19/21 Due: 03/19/22

Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03284151 Org: User:
Start: 01/31/15 End: 01/31/23 Due: 01/31/24

Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04948840 Org: User:
Start: 04/01/22 End: 12/31/24 Due: 12/31/25

Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk

Phase: N/A Priority: Normal
NCT ID: NCT05433974 Org: User:
Start: 10/01/22 End: 06/01/24 Due: 06/01/25

CyberKnife for Prostate Cancer Patients Aged 70 y or More

Phase: N/A Priority: Normal
NCT ID: NCT03235557 Org: User:
Start: 10/31/14 End: 12/31/21 Due: 12/31/22

Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala

Phase: N/A Priority: Normal
NCT ID: NCT03209128 Org: User:
Start: 04/20/17 End: 03/19/21 Due: 03/19/22